CORD-19:12f9d385be20fc59e52070d0ce51daa580ec0f0c / 12933-13259 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T89","span":{"begin":0,"end":326},"obj":"Sentence"}],"text":"Development of ARDS varied with the codon 54 genotype (p \u003c .05), with patients who were homozygous for the variant codon 54B allele having an increased odds of developing ARDS compared with homozygotes or heterozygotes for the wild-type A allele (odds ratio [OR], 5.0, 95% confidence interval [CI], 1.3-20; p = .02) (Fig. 3) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T89","span":{"begin":0,"end":326},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Development of ARDS varied with the codon 54 genotype (p \u003c .05), with patients who were homozygous for the variant codon 54B allele having an increased odds of developing ARDS compared with homozygotes or heterozygotes for the wild-type A allele (odds ratio [OR], 5.0, 95% confidence interval [CI], 1.3-20; p = .02) (Fig. 3) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T83","span":{"begin":15,"end":19},"obj":"Disease"},{"id":"T84","span":{"begin":171,"end":175},"obj":"Disease"},{"id":"T17805","span":{"begin":15,"end":19},"obj":"Disease"},{"id":"T27063","span":{"begin":171,"end":175},"obj":"Disease"}],"attributes":[{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A8290","pred":"mondo_id","subj":"T17805","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A43735","pred":"mondo_id","subj":"T27063","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Development of ARDS varied with the codon 54 genotype (p \u003c .05), with patients who were homozygous for the variant codon 54B allele having an increased odds of developing ARDS compared with homozygotes or heterozygotes for the wild-type A allele (odds ratio [OR], 5.0, 95% confidence interval [CI], 1.3-20; p = .02) (Fig. 3) ."}